Esperion Therapeutics’ Royalty Purchase Agreement with OMERS

Leila Ahmed North America Legal Chronicle
Tagged:

Gibson Dunn & Crutcher advised Esperion Therapeutics, Inc. on the deal.Esperion Therapeutics, Inc. (Nasdaq: ESPR) announced that it has entered into a Royalty Purchase Agreement (the…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here